Stocktoria
BIOCRYST PHARMACEUTICALS INC BCRX
BIOCRYST PHARMACEUTICALS INC institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 19,956,255 | $123.3M | 9.13% |
| TWO SIGMA INVESTMENTS, LP | 6,392,628 | $60.9M | 2.92% |
| CITADEL ADVISORS LLC | 1,214,946 | $11.6M | 0.56% |
| RENAISSANCE TECHNOLOGIES LLC | 776,990 | $7.4M | 0.36% |
| Bridgewater Associates, LP | 638,054 | $6.1M | 0.29% |
| AQR CAPITAL MANAGEMENT LLC | 440,141 | $4.2M | 0.2% |
| MILLENNIUM MANAGEMENT LLC | 317,721 | $3.0M | 0.15% |
| D. E. Shaw & Co., Inc. | 302,101 | $2.9M | 0.14% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.